Elevance Health cash flow statement
In fiscal 2025, Elevance Health's operations generated $4.29bn of cash; it spent $1.12bn on capital projects, leaving free cash flow of $3.17bn. It returned $1.53bn in dividends and $2.60bn through buybacks.
Cash flow statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 3.0 | 1.4 | 3.4 | 2.7 | 3.1 | 3.4 | 4.2 | 3.3 | 4.2 | 3.8 | 6.1 | 10.7 | 8.4 | 8.4 | 8.1 | 5.8 | 4.3 | 7.6 |
| Depreciation and amortisation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 1.1 | 1.1 | 1.2 | 1.3 | 1.7 | 1.7 | 1.4 | 1.5 | 1.5 |
| Stock-based pay | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.2 |
| Capital spending | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.7 | 0.6 | 0.6 | 0.8 | 1.2 | 1.1 | 1.0 | 1.1 | 1.2 | 1.3 | 1.3 | 1.1 | 1.1 |
| Free cash flow | 2.7 | 1.0 | 2.9 | 2.2 | 2.4 | 2.7 | 3.6 | 2.7 | 3.4 | 2.6 | 5.0 | 9.7 | 7.3 | 7.2 | 6.8 | 4.6 | 3.2 | 6.5 |
| Free cash flow after stock pay | 2.5 | 0.8 | 2.7 | 2.1 | 2.3 | 2.5 | 3.4 | 2.5 | 3.2 | 2.4 | 4.7 | 9.4 | 7.0 | 7.0 | 6.5 | 4.4 | 2.9 | 6.3 |
| Dividends paid | — | 0.0 | 0.4 | 0.4 | 0.4 | 0.5 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | 1.0 | 1.1 | 1.2 | 1.4 | 1.5 | 1.5 | 1.5 |
| Share buybacks | 2.6 | 4.4 | 3.0 | 2.5 | 1.6 | 3.0 | 1.5 | 0.0 | 2.0 | 1.7 | 1.7 | 2.7 | 1.9 | 2.3 | 2.7 | 2.9 | 2.6 | 2.2 |
| Shares issued | — | — | — | — | — | — | — | 0.0 | 0.0 | 1.3 | 0.0 | 0.0 | — | — | — | — | — | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 706 | 1,017 | 2,054 | 1,135 | 84 | 4,332 | 1,913 | 1,267 |
| Depreciation and amortisation | 706 | 373 | 380 | 387 | 406 | 354 | 366 | 363 |
| Stock-based pay | −29 | 81 | 81 | 84 | 30 | 55 | 75 | 80 |
| Capital spending | 322 | 196 | 267 | 360 | 293 | 235 | 287 | 267 |
| Free cash flow | 384 | 821 | 1,787 | 775 | −209 | 4,097 | 1,626 | 1,000 |
| Free cash flow after stock pay | 413 | 740 | 1,706 | 691 | −239 | 4,042 | 1,551 | 920 |
Compare with peers
- Centene Corporation cash flow
- Humana cash flow
- UnitedHealth Group cash flow
- Molina Healthcare, Inc. cash flow
- Oscar Health, Inc. cash flow
Head to head: CNC vs ELVELV vs HUMELV vs UNHELV vs MOH
More: Managed Health Care stocks compared, Health Care sector, rankings of US companies